Literature DB >> 12939323

Quantification of metamorphopsia in patients with epiretinal membranes.

Chota Matsumoto1, Eiko Arimura, Sachiko Okuyama, Sonoko Takada, Shigeki Hashimoto, Yoshikazu Shimomura.   

Abstract

PURPOSE: To quantify the degree of metamorphopsia in patients with idiopathic epiretinal membranes (ERMs), by use of a new metamorphopsia chart (M-CHARTS) developed by the authors.
METHODS: These M-CHARTS had 19 dotted lines with dot intervals of between 0.2 degrees (fine) and 2.0 degrees (coarse) visual angles. As the dot intervals were changed from fine to coarse, a decrease in the severity of metamorphopsia was noted. In this study, the minimum visual angle of the dotted lines needed to cause the metamorphopsia to disappear was measured in 51 eyes of 51 patients with ERM. The metamorphopsia scores were compared with the stages of ERM classified by scanning laser ophthalmoscope (SLO) images.
RESULTS: In patients with ERM, the metamorphopsia score increased depending on the severity of membrane proliferation classified by SLO images. The scores obtained from the horizontal dotted lines were larger than those of the vertical lines in advanced stages of ERM.
CONCLUSIONS: M-CHARTS provide a very simple and useful method for evaluating the severity of metamorphopsia in patients with ERM.

Entities:  

Mesh:

Year:  2003        PMID: 12939323     DOI: 10.1167/iovs.03-0117

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  43 in total

1.  Two-year results of metamorphopsia, visual acuity, and optical coherence tomographic parameters after epiretinal membrane surgery.

Authors:  Takamasa Kinoshita; Hiroko Imaizumi; Hirotomo Miyamoto; Takashi Katome; Kentaro Semba; Yoshinori Mitamura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-08-30       Impact factor: 3.117

2.  Comparison of visual acuity, metamorphopsia, and aniseikonia in patients with an idiopathic epiretinal membrane.

Authors:  Atsuhiro Tanikawa; Yoshiaki Shimada; Masayuki Horiguchi
Journal:  Jpn J Ophthalmol       Date:  2018-04-06       Impact factor: 2.447

3.  Improvement of horizontal macular contraction after surgical removal of epiretinal membranes.

Authors:  H K Yang; S J Kim; Y S Jung; K G Kim; J H Kim; H G Yu
Journal:  Eye (Lond)       Date:  2011-04-01       Impact factor: 3.775

4.  Retinal thickness in eyes with idiopathic macular hole after vitrectomy with internal limiting membrane peeling.

Authors:  Kouichi Ohta; Atsuko Sato; Emi Fukui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-11       Impact factor: 3.117

5.  Assessment of retinal layers and visual rehabilitation after epiretinal membrane removal.

Authors:  Jae Hui Kim; Se Woong Kang; Min Gui Kong; Hyo Shin Ha
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-09       Impact factor: 3.117

6.  Relationship between metamorphopsia and foveal microstructure in patients with branch retinal vein occlusion and cystoid macular edema.

Authors:  Tomoya Murakami; Fumiki Okamoto; Masaharu Iida; Yoshimi Sugiura; Yoshifumi Okamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-05-12       Impact factor: 3.117

7.  Novel quantitative assessment of metamorphopsia in maculopathy.

Authors:  Emily Wiecek; Kameran Lashkari; Steven C Dakin; Peter Bex
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-18       Impact factor: 4.799

8.  Vision-related quality of life and visual function following intravitreal bevacizumab injection for persistent diabetic macular edema after vitrectomy.

Authors:  Yoshifumi Okamoto; Fumiki Okamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Jpn J Ophthalmol       Date:  2014-04-29       Impact factor: 2.447

9.  Results of macular pucker surgery: 1- and 5-year follow-up.

Authors:  M Dimitri Bouwens; Floris de Jong; Paul Mulder; Jan C van Meurs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-16       Impact factor: 3.117

Review 10.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.